Marc Frahm

Stock Analyst at TD Cowen

(0.11)

# 4,265

Out of 4,886 analysts

15

Total ratings

15.38%

Success rate

-31.72%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Marc Frahm

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SANA Sana Biotechnology	Upgrades: Buy	n/a	$3.10	-	2	Jan 8, 2025
	TBPH Theravance Biopharma	Maintains: Hold	$10 → $9	$11.27	-20.14%	3	Aug 6, 2024
	INCY Incyte	Maintains: Buy	$88 → $80	$67.27	+18.92%	3	May 1, 2024
	CGEM Cullinan Therapeutics	Initiates: Outperform	n/a	$7.43	-	1	Jun 15, 2023
	XLO Xilio Therapeutics	Initiates: Outperform	n/a	$0.70	-	1	Nov 16, 2021
	NUVL Nuvalent	Initiates: Outperform	n/a	$77.92	-	1	Aug 23, 2021
	ELEV Elevation Oncology	Initiates: Outperform	n/a	$0.38	-	1	Jul 20, 2021
	JANX Janux Therapeutics	Initiates: Outperform	n/a	$23.99	-	1	Jul 6, 2021
	DAWN Day One Biopharmaceuticals	Initiates: Outperform	n/a	$6.63	-	1	Jun 21, 2021
	BDTX Black Diamond Therapeutics	Initiates: Outperform	n/a	$2.50	-	1	Feb 24, 2020

Sana Biotechnology

Jan 8, 2025

Upgrades: Buy

Price Target: n/a

Current: $3.10

Upside: -

Theravance Biopharma

Aug 6, 2024

Maintains: Hold

Price Target: $10 → $9

Current: $11.27

Upside: -20.14%

Incyte

May 1, 2024

Maintains: Buy

Price Target: $88 → $80

Current: $67.27

Upside: +18.92%

Cullinan Therapeutics

Jun 15, 2023

Initiates: Outperform

Price Target: n/a

Current: $7.43

Upside: -

Xilio Therapeutics

Nov 16, 2021

Initiates: Outperform

Price Target: n/a

Current: $0.70

Upside: -

Nuvalent

Aug 23, 2021

Initiates: Outperform

Price Target: n/a

Current: $77.92

Upside: -

Elevation Oncology

Jul 20, 2021

Initiates: Outperform

Price Target: n/a

Current: $0.38

Upside: -

Janux Therapeutics

Jul 6, 2021

Initiates: Outperform

Price Target: n/a

Current: $23.99

Upside: -

Day One Biopharmaceuticals

Jun 21, 2021

Initiates: Outperform

Price Target: n/a

Current: $6.63

Upside: -

Black Diamond Therapeutics

Feb 24, 2020

Initiates: Outperform

Price Target: n/a

Current: $2.50

Upside: -